INVO Fertility, Inc.
IVFINVO Fertility is a healthcare services and technology company dedicated to expanding access to assisted reproductive technology (ART) through a dual-model approach.
Table of contents
Earnings
Next report
Aug 13, 2026 (In 2 weeks)Competitors
By market cap
Profile
INVO Fertility is a healthcare services and technology company dedicated to expanding access to assisted reproductive technology (ART) through a dual-model approach. The company operates a growing network of fertility clinics while commercializing its proprietary INVOcell medical device, which enables intravaginal culture (IVC) as a cost-effective alternative to traditional IVF. Its core value proposition centers on democratizing fertility care by reducing laboratory costs and increasing patient capacity in underserved markets.
A specialized provider of alternative ART solutions, positioning itself as a lower-cost, high-access alternative to conventional IVF through proprietary IVC technology.
Questions, answered.
- What is INVO Fertility, Inc.'s market cap?
- INVO Fertility, Inc. (IVF) has a market capitalization of $1.7M and trades on NASDAQ.
- Who are INVO Fertility, Inc.'s competitors?
- INVO Fertility, Inc.'s key competitors include Femasys Inc. Common Stock, Progyny, Inc. Common Stock, Iovance Biotherapeutics, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does INVO Fertility, Inc. partner with?
- INVO Fertility, Inc.'s notable partners include HRCFG, LLC, Bloom Fertility, LLC, NextPhase Medical Devices, and others.
- What subsidiaries does INVO Fertility, Inc. have?
- INVO Fertility, Inc.'s subsidiaries include Wood Violet Fertility, LLC, Bio X Cell, Inc, INVO Centers LLC, and others.
- Where is INVO Fertility, Inc. headquartered?
- INVO Fertility, Inc. is headquartered in United States of America and employs approximately 32 people. It has been publicly traded since 2008.